FERRANTE, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 888
EU - Europa 264
AS - Asia 125
AF - Africa 55
SA - Sud America 4
OC - Oceania 1
Totale 1.337
Nazione #
US - Stati Uniti d'America 882
CN - Cina 87
FI - Finlandia 64
NG - Nigeria 54
DE - Germania 38
IE - Irlanda 38
IT - Italia 38
IN - India 18
SE - Svezia 17
FR - Francia 16
MK - Macedonia 13
NL - Olanda 10
RU - Federazione Russa 9
PH - Filippine 6
BE - Belgio 5
GB - Regno Unito 5
CA - Canada 3
CU - Cuba 3
IL - Israele 3
JP - Giappone 3
PE - Perù 3
CH - Svizzera 2
GR - Grecia 2
HK - Hong Kong 2
PL - Polonia 2
RS - Serbia 2
TR - Turchia 2
TW - Taiwan 2
UA - Ucraina 2
AU - Australia 1
BR - Brasile 1
ID - Indonesia 1
RO - Romania 1
SA - Arabia Saudita 1
UG - Uganda 1
Totale 1.337
Città #
Chandler 176
Wilmington 111
Shanghai 85
Boardman 66
Helsinki 64
Benin City 54
Ashburn 51
New York 51
San Mateo 51
Dublin 38
Ann Arbor 28
Lawrence 22
Princeton 22
Leawood 19
Milan 18
Woodbridge 16
Pune 15
Paris 14
Amsterdam 10
Los Angeles 9
Skopje 8
Fairfield 6
Phoenix 6
Abbiategrasso 5
Bitola 5
Brussels 5
Falkenstein 5
Seattle 5
London 4
Moscow 4
Augsburg 3
Frankfurt am Main 3
Havana 3
Lima 3
Olongapo City 3
Toronto 3
Des Moines 2
Gdansk 2
Hangzhou 2
Houston 2
Kocaeli 2
Las Pinas 2
Lübeck 2
Mykolayiv 2
Rome 2
Sale Marasino 2
Santa Clara 2
St Petersburg 2
Taipei 2
Venegono Superiore 2
Belgrade 1
Berlin 1
Buffalo 1
Cagayan de Oro 1
Cambridge 1
Canberra 1
Central 1
Chicago 1
Clearwater 1
Delhi 1
Dundee 1
Florence 1
Gallarate 1
Gunzenhausen 1
Izhevsk 1
Jakarta 1
Monmouth Junction 1
Norwalk 1
Novokuznetsk 1
Queens 1
Redmond 1
Redwood City 1
Riyadh 1
Rozzano 1
San Diego 1
Sindelfingen 1
Tappahannock 1
Tübingen 1
Totale 1.047
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 109
Interleukin-6 Trans-Signaling and Risk of Future Cardiovascular Events: A New Avenue for Atheroprotection? 61
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 59
How should I treat a DES restenosis in a graft anastomosis with challenging access and multiple previous coronary interventions? 58
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 56
Endovascular treatment vs. intravenous thrombolysis alone for ischaemic stroke: a meta-analysis of randomised controlled trials 55
Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction. 55
Dual Antiplatelet Therapy Continuation Beyond 1 Year After Drug-Eluting Stents: A Meta-Analysis of Randomized Trials 55
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 55
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 55
Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials 52
Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease. 51
Abdominal Aortic Calcification as a Marker of Relationship Between Atherosclerosis and Skeletal Fragility 48
ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes 45
Major Bleeding Associated With Very Early Subclinical Valve Thrombosis After Transcatheter Aortic Valve Replacement 38
"Fogarty-like" removal of large coronary thrombus 38
Distal vs Conventional Radial Access for Coronary Angiography and/or Intervention 34
Mitral Valve Stenosis after Transcatheter Aortic Valve Replacement: Case Report and Review of the Literature. 34
Impact of myocardial injury on mortality in patients with COVID-19: a meta-analysis 34
Imaging of coronary flow capacity: is there a role for dynamic CT perfusion imaging? 34
Clinical Effects of Dual Antiplatelet Therapy or Aspirin Monotherapy after Acute Minor Ischemic Stroke or Transient Ischemic Attack, a Meta-Analysis 32
Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials 32
Association Between Colchicine Treatment and Clinical Outcomes in Patients with Coronary Artery Disease: Systematic Review and Meta-analysis 31
Percutaneous Left Atrial Appendage Closure: Rational, Patient Selection, and Preoperative Evaluation. 26
Secondary hyperparathyroidism and thoracic vertebral fractures in heart failure middle-aged patients: a 3-year prospective study 23
Dual antiplatelet therapy duration after percutaneous coronary intervention with drug-eluting stents: how short can we go? 20
Risk factors for myocardial injury and death in patients with COVID-19: insights from a cohort study with chest computed tomography 20
Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study 20
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 19
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials 18
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry 17
C-reactive Protein Serum Levels Predict in Stent Restenosis Pattern After Drug Eluting Stent Implantation 16
[Percutaneous mitral valve repair in acute mitral regurgitation] 15
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 14
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 13
MicroRNA-132 Inhibition Prevents Myocardial Hypertrophy and Heart Failure in Pigs: Making Sense Out of Antisense 7
One-Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus-Eluting Stents in High Bleeding Risk Patients 7
MitraClip Treatment for Severe Mitral Regurgitation Due to Chordae Rupture Following Impella CP Support in a Patient With Severe Aortic Stenosis 5
Nebivolol versus placebo in patients undergoing anthracyclines (CONTROL Trial): rationale and study design 5
Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial 4
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 3
The Smokers Health Multiple ACtions (SMAC-1) Trial: Study Design and Results of the Baseline Round 3
Validation of a Contemporary Acute Kidney Injury Risk Score in Patients With Acute Coronary Syndrome 2
Reply: Distal Transradial Access in Acute Coronary SyndromesShould We Give the First Try? 1
Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention 1
Totale 1.380
Categoria #
all - tutte 8.638
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.638


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021239 6 1 3 1 5 61 30 15 50 27 1 39
2021/2022139 3 4 5 26 2 1 4 17 9 3 47 18
2022/2023560 52 17 30 77 85 37 3 42 108 51 46 12
2023/2024442 49 26 75 59 23 68 57 47 18 20 0 0
Totale 1.380